Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: Randomized controlled phase I trial in the Philippines
- 6 April 2011
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 29 (22), 3863-3872
- https://doi.org/10.1016/j.vaccine.2011.03.057
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico CityThe Pediatric Infectious Disease Journal, 2011
- A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes inFlavivirus‐Naive AdultsThe Journal of Infectious Diseases, 2010
- Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever–dengue vaccinesJournal of Virological Methods, 2008
- Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue VirusesViral Immunology, 2008
- Safety of Typhim Vi Vaccine in a Postmarketing Observational StudyJournal of Travel Medicine, 2007
- Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults☆Vaccine, 2006
- Dengue viral infectionsPublished by Oxford University Press (OUP) ,2004
- Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent VaccineJournal of Virology, 2001
- Isolation and partial characterization of dengue virus type 2 and 4 strains from dengue fever and dengue haemorrhagic fever patients from Mindanao, Republic of the PhilippinesTropical Medicine & International Health, 2000
- A plaque technique for the titration of yellow fever virus and antiseraTransactions of the Royal Society of Tropical Medicine and Hygiene, 1959